Registration is Open!
34th Annual Meeting and Scientific Symposium
December 7-10, 2023
Rancho Bernardo Inn
San Diego, CA
Learn More
2023 Advanced Addiction Psychopharmacology Course
Learn More
NIDA-AAAP Mentor-Facilitated Training Award Application Open!
All applications are due by Thursday, November 30, 2023.
Learn More
Psychedelics in the Treatment of Substance Use Disorders: What Clinicians Need to Know (Enduring Material)
Learn More
Addiction Psychiatry Advanced Psychotherapy Curriculum
Join us for our new monthly live learning series targeted towards Addiction Psychiatry fellows and faculty.
Learn More
Previous slide
Next slide

The American Journal on Addictions (AJA)


The official journal of the American Academy of Addiction Psychiatry. The Academy encourages research on the etiology, prevention, identification, and treatment of substance use disorders; thus, the journal provides a forum for the dissemination of information in the extensive field of addiction.

Ways to get involved


Become part of a growing and scientifically robust community of Addiction Psychiatrists committed to evidence-based practices and expanding the visibility and role of Addiction Psychiatrists.

Annual Meeting

AAAP's Annual Meeting, Addictions and Their Treatment Course, and Advanced Addiction Psychopharmacology Course provide the latest advances in research and clinical practice.


ABPN offers certification in the subspecialty of Addiction Psychiatry to physicians who have completed accredited residency programs in general psychiatry.


Donations will help us to further our goals and attend to issues of general interest to membership..


AAAP has been on the forefront advocating for our membership, but also for the patients they treat through involvement in developing national policy.

Job Board

AAAP maintains a job listing as a resource for all interested in the field of Addiction Psychiatry.

Learn more about AAAP

Educational Opportunities

AAAP offers a variety of educational resources to help physicians and health professionals provide the highest standards of care to their patients.


AAAP leads a nationwide coalition of professional organizations on a variety of SAMHSA grants addressing the Opioid crisis.


Helpful materials for clinicians as well as patients and families on treating substance use disorders.


AAAP has an active and vibrant selection of committees. Getting involved is always rewarding and a great way to meet new colleagues and network.

Changing news about changing lives.

Drug Enforcement Administration, Department of Justice

July 11, 2023

As Congressionally-mandated, medical practitioners have a new role to help patients fighting to sustain recovery and prevent opioid overdoses. All medical registrants submitting a new or renewing a current registration must attest to completing an eight-hour training to treat patients overcoming opioid and other substance use disorders.
White House, Washington

March 29, 2023

WASHINGTON, D.C. – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), issued a statement following the U.S. Food and Drug Administration (FDA) approval of the first nonprescription, “over-the-counter” (OTC) Naloxone nasal spray (Narcan). Naloxone – a medicine that can reverse an opioid-related overdose – has been shown to be a critical tool to prevent fatal overdoses and save lives.

March 27, 2023

PCSS wanted to share this email from the federal Drug Enforcement Agency regarding new training requirements.